
November 3, 2024
BioFactura Receives $7.8 Million in Funding for Contract Options for its Smallpox Biodefense Therapeutic
FREDERICK, MARYLAND, November 4, 2024: BioFactura, Inc. recently announced contract option activations totaling $7.8 million by the Biomedical Advanced Research…